Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Ingenta (ING) by Steve Moore in ShareProphets
- Avoid Videndum (VID) by Steve Moore in ShareProphets
- Watch Funding Circle Holdings (FCH) by Mark Hartley in The Motley Fool
- Sell Dr. Martens (DOCS) by Steve Moore in ShareProphets
- Hold Persimmon (PSN) by Berenberg
- Buy Atalaya Mining (ATYM) by Berenberg
- Buy Alfa Financial Software Holdings (ALFA) by Berenberg
- Avoid British American Tobacco (BATS) by Royston Wild in The Motley Fool
- Avoid BP (BP.) by Royston Wild in The Motley Fool
- Avoid BT Group (BT.A) by Royston Wild in The Motley Fool
- Buy RS Group (RS1) by John Ficenec in The Times - Tempus
- Buy Johnson Matthey (JMAT) by Jefferies
- Hold Zigup (ZIG) by Jefferies
- Watch Solid State (SOLI) by Steve Moore in ShareProphets
- Buy Forterra (FORT) by Jefferies
- Buy Conduit Holdings Limited Com Shs (DI) (CRE) by Jefferies
- Buy Intermediate Capital Group (ICG) by Jefferies
- Buy Rolls-Royce Holdings (RR.) by Jefferies
- Buy Persimmon (PSN) by Jefferies
- Avoid Forterra (FORT) by Steve Moore in ShareProphets
Hikma Pharmaceuticals (HIK) Share Price
Health Care Sector
NOTE: This is based on 402 open tips for Hikma Pharmaceuticals (HIK)
| Latest Bid : 1,640.00p | Latest Ask : 1,643.00p |
| High Today : 1,674.00p | Low Today : 1,633.00p |
| This Years High : 1,762.00p | This Years Low : 1,191.00p |
| Volume : 134,547 | MKT Cap : £3613.35M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Hikma Pharmaceuticals (HIK) Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Hikma Pharmaceuticals (HIK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Berenberg | Premium Only | 2026-11-09 09:40:00 09/11/2026 | -1.86% |
| Buy | Deutsche Bank | Premium Only | 2026-11-06 10:40:00 06/11/2026 | 0.43% |
| Buy | Jefferies | Premium Only | 2026-11-05 10:30:00 05/11/2026 | -1.21% |
| Buy | Jefferies | Premium Only | 2026-09-25 11:15:00 25/09/2026 | 1.74% |
| Buy | Jefferies | Premium Only | 2026-08-25 09:34:00 25/08/2026 | -0.06% |
Hikma Pharmaceuticals (HIK) Recent Short Position Updates
| Position | Date |
|---|---|
| 2.01% | 10/11/2026 |
| Latest Bid : 1,640.00p | Latest Ask : 1,643.00p |
| High Today : 1,674.00p | Low Today : 1,633.00p |
| This Years High : 1,762.00p | This Years Low : 1,191.00p |
| Volume : 134,547 | MKT Cap : £3613.35M |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Berenberg | Premium Only | 2026-11-09 09:40:00 09/11/2026 | -1.86% |
| Buy | Deutsche Bank | Premium Only | 2026-11-06 10:40:00 06/11/2026 | 0.43% |
| Buy | Jefferies | Premium Only | 2026-11-05 10:30:00 05/11/2026 | -1.21% |
| Buy | Jefferies | Premium Only | 2026-09-25 11:15:00 25/09/2026 | 1.74% |
| Buy | Jefferies | Premium Only | 2026-08-25 09:34:00 25/08/2026 | -0.06% |